Sun Pharma Advanced Research Company Limited (NSE:SPARC)
146.08
+1.03 (0.71%)
Aug 22, 2025, 3:29 PM IST
NSE:SPARC Market Cap
NSE:SPARC has a market cap or net worth of 47.41 billion as of August 22, 2025. Its market cap has decreased by -31.38% in one year.
Market Cap
47.41B
Enterprise Value
50.08B
Revenue
645.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
146.08
Market Cap Chart
Since July 18, 2007, NSE:SPARC's market cap has increased from 17.19B to 47.41B, an increase of 175.83%. That is a compound annual growth rate of 5.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 22, 2025 | 47.41B | -27.16% |
Dec 31, 2024 | 65.08B | -30.07% |
Dec 29, 2023 | 93.07B | 62.05% |
Dec 30, 2022 | 57.43B | -24.01% |
Dec 31, 2021 | 75.58B | 48.86% |
Dec 31, 2020 | 50.77B | 24.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,939.23B |
Divi's Laboratories | 1,633.03B |
Cipla | 1,286.59B |
Apollo Hospitals Enterprise | 1,139.13B |
Mankind Pharma | 1,075.90B |
Zydus Lifesciences | 994.96B |
Fortis Healthcare | 705.43B |
Alkem Laboratories | 648.76B |